This study looks at how personality affects the improvement in quality of life for people with Parkinson's Disease (PD) using a treatment called Continuous Subcutaneous Apomorphine Infusion (CSAI). Parkinson's Disease is a brain disorder that causes tremors, stiffness, and difficulty with movement. **CSAI** is a treatment where a medicine called apomorphine is slowly delivered under the skin to help manage symptoms. Researchers want to see if certain personality traits, like how people react to new things or work with others, can predict how well CSAI works. They will use a questionnaire called the Temperament and Character Inventory (TCI) to measure personality. The study will also consider other factors like social support and coping strategies to see how these affect treatment outcomes. **Key Points:** - **Participants**: Adults aged 40-75 with Parkinson's and specific movement issues, who are already planning to start CSAI. - **Exclusions**: People with certain mental health issues, cognitive impairments, or other severe health conditions. - **Purpose**: To better understand who might benefit most from CSAI and how personality and other factors impact quality of life improvements. This study does not involve any additional treatment visits beyond routine care.